VP of Business Development Medical Device jobs
- Contribute to the development and consistent application of a structured evaluation framework and scoring criteria that allow assets to be compared across…
- View all Thermo Fisher Scientific jobs - California jobs - Vice President of Strategy jobs in California
- Salary Search: ED/VP Medical Science & Strategy – Oncology, China Asset Evaluation and Global Development (Mandarin Proficiency) salaries in California
- See popular questions & answers about Thermo Fisher Scientific
- Prowind GmbHWoodstock, ON N4S 6J5
- $160,000–$200,000 a year
- Full-time
- Experience in financial analysis and evaluation of development projects.
- Proven experience in project development, preferably in wind energy and strong…
- Teladoc HealthRemote
- $150,000–$200,000 a year
- Yes, interim responsibility of overseeing a team of sales and client management professionals.
- Achieve the established revenue objectives, including business…
- View all Teladoc Health jobs - Remote jobs - Director of Partnerships jobs in Remote
- Salary Search: Senior Director, Growth and Partnerships salaries in Remote
- See popular questions & answers about Teladoc Health
- DayforceRemote in Canada
- $224,000–$350,000 a year
- Own the partner strategy and growth of Dayforce Build, sharing ownership of the platform roadmap with Product and Engineering.
- myTomorrowsRemote in Canada
- Full-time
- 5+ years of experience in partnership development, business development or sales roles, with a strong focus on contracting and closing deals within the…
- University Health NetworkToronto, ON
- $138,185–$172,731 a year
- Full-time
- Minimum 10 years of experience in business development, licensing, strategic partnerships, commercialization, or related fields.
- View all University Health Network jobs - Toronto jobs - Business Development Manager jobs in Toronto, ON
- Salary Search: Principal, Business Development & Commercialization, Clinical Research and Early Cancer Detection salaries in Toronto, ON
- See popular questions & answers about University Health Network
- University Health NetworkToronto, ON
- $138,185–$172,731 a year
- Full-time
- Minimum 10 years of experience in business development, licensing, strategic partnerships, commercialization, or related fields.
- View all University Health Network jobs - Toronto jobs - Business Development Manager jobs in Toronto, ON
- Salary Search: Principal, Business Development & Commercialization, Clinical Research and Early Cancer Detection salaries in Toronto, ON
- See popular questions & answers about University Health Network
- Veeva SystemsRemote
- $115,000–$165,000 a year
- Full-time
- Drive practice growth by contributing to business development and internal IP creation.
- In this role, you will collaborate closely with internal teams across…
- View all Veeva Systems jobs - Remote jobs - Business Consultant jobs in Remote
- Salary Search: Business Consultant - Medical Content salaries in Remote
- See popular questions & answers about Veeva Systems
Head of Business Development, Investor Network
Easily applyPairsRemote in Canada- $200,000–$400,000 a year
- Full-time
- Run the weekly rhythm, a pipeline and network review (CRM), a review of every win and loss, KPIs, and a one to one with every associate.
View similar jobs with this employerVP, Engagement Strategy
Easily applyBGBxRemote in Mississauga, ON- $200,000–$240,000 a year
- Full-time
- Maintain the strategic throughline as work moves from strategy into creative development, implementation, and optimization.
View similar jobs with this employerAccentureHybrid work in Calgary, AB- $131,700–$278,100 a year
- Full-time
- 8+ years of business development, sales, alliance, or consulting experience.
- 10+ years of complex pursuit management and opportunity development experience.
- 49North - An MDA Space CompanyHybrid work in Ottawa, ON K1A 1B9
- $135,200–$185,900 a year
- Permanent
- Experience: 5+ years of progressive experience in capture management or technical business development within the naval or aerospace defence sector, with a…
View similar jobs with this employer49North (An MDA Space Company)Hybrid work in Ottawa, ON K1A 1B9- $156,000–$257,000 a year
- Permanent
- Lead development & execution of capture plans mapping out win themes, competitor ghosting strategies and value propositions.
- SiemensHybrid work in Oakville, ON L6H 0H6
- Full-time
- Proven track record of driving business growth, achieving sales objectives, and managing strategic customer relationships within complex industrial environments…
- View all Siemens jobs - Oakville jobs - Director of Science jobs in Oakville, ON
- Salary Search: Director, Americas, Life Sciences Vertical salaries in Oakville, ON
- See popular questions & answers about Siemens
- McKessonHybrid work in Mississauga, ON L4V 1W2
- $151,200–$201,600 a year
- Demonstrated success developing and executing strategic business development plans.
- 15+ years of demonstrated success in sales and/or marketing, with a…
- GoogleWaterloo, ON
- $224,000–$311,000 a year
- Full-time
- 15 years of experience in partner management, product management, business development, sales, or channel development in the technology industry.
By creating a job alert, you agree to our Terms . You can change your consent settings at any time by unsubscribing or as detailed in our terms.
Career Resources:
Job Post Details
ED/VP Medical Science & Strategy – Oncology, China Asset Evaluation and Global Development (Mandarin Proficiency)
ED/VP Medical Science & Strategy – Oncology, China Asset Evaluation and Global Development (Mandarin Proficiency)
Job details
Full job description
Work Schedule
Standard (Mon-Fri)Environmental Conditions
OfficeJob Description
At Thermo Fisher Scientific, you’ll discover meaningful work that makes a positive impact on a global scale. Join our colleagues in bringing our Mission to life – enabling our customers to make the world healthier, cleaner and safer. We provide our teams with the resources needed to achieve individual career goals while taking science a step beyond through research, development and delivery of life-changing therapies. With clinical trials conducted in more than 100 countries and ongoing development of novel frameworks for clinical research through our PPD clinical research portfolio, our work spans laboratory, digital and decentralized clinical trial services. Your determination to deliver quality and accuracy will improve health outcomes that people and communities depend on – now and in the future.
- Must be legally authorized to work in the United States or Canada without sponsorship.
- Must be able to pass a comprehensive background check, which includes a drug screening (where applicable).
- Must be able to work with regular overlap to support China working hours.
Position Summary:
Thermo Fisher Scientific is seeking a physician with extensive oncology clinical development experience to join a cross-functional team that identifies, evaluates, and partners with biotechnology companies and academic laboratories in China that are developing novel oncology therapeutics. Many of these programs generate promising preclinical and early-phase clinical data in China but have not yet established the regulatory, operational, and strategic foundation required to advance into multiregional trials and global registration.
The incumbent will evaluate preclinical and clinical-stage oncology assets, assess which are most likely to succeed in global development, and help shape partnerships through which Thermo Fisher Scientific and its PPD clinical research business support these assets in their transition from early-phase trials in China to global pivotal trials and registration with regulators such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
As a member of a larger diligence team, the incumbent will provide the medical and scientific judgment that underpins strategic recommendations to Thermo Fisher Scientific senior leadership as to which assets and companies should be prioritized and which should be deprioritized. The position requires proven ability to drive both strategic and measurable business outcomes. The incumbent’s oncology track record and expertise must be extensive enough to ensure recognition as a peer of senior medical and scientific leaders in the pharmaceutical and biotechnology industries.
Key Responsibilities:
1. Asset Identification and Scientific Due Diligence
- Identify and screen preclinical and clinical-stage oncology assets originating from biotechnology companies, academic laboratories, and research hospitals in China, drawing on scientific literature, conference presentations, regulatory and trial registry records, and direct engagement with sponsors and investigators.
- Evaluate the scientific foundation of each asset, including mechanism of action, target validation, biological rationale, preclinical pharmacology and toxicology, and translational and biomarker strategy.
- Assess differentiation relative to current standard of care and to competing assets in development globally, across modalities including antibody–drug conjugates, bispecific antibodies, cell and gene therapies, and targeted small molecules.
- Critically appraise early-phase clinical data generated in China, including dose-escalation design, dose selection and optimization, safety and tolerability, pharmacokinetics, and preliminary efficacy, with attention to study design quality, endpoint selection, data integrity, and Good Clinical Practice (GCP) compliance.
- Assess the likely applicability of China-generated clinical data to global regulatory submissions, taking into account differences in standard of care, patient populations, and trial conduct, with reference to International Council for Harmonisation (ICH) guidelines E5 (ethnic factors in the acceptability of foreign clinical data) and E17 (multiregional clinical trials) and to FDA regulations and guidance on the use of foreign clinical data.
- Define the remaining path to global registration for each asset, including indication and line-of-therapy selection, likely regulatory expectations in the United States, European Union, and other major markets, and the principal clinical, regulatory, and technical risks.
- Collaborate with functional experts to assess nonclinical package completeness and chemistry, manufacturing, and controls (CMC) readiness for global development.
2. Strategic Recommendations and Portfolio Prioritization
- Synthesize scientific, clinical, regulatory, and commercial findings into clear, evidence-based recommendations on whether each asset and company should be prioritized, monitored, or deprioritized.
- Contribute to the development and consistent application of a structured evaluation framework and scoring criteria that allow assets to be compared across modalities, tumor types, and stages of development.
- Prepare and present diligence findings and recommendations to Thermo Fisher Scientific senior leadership and governance forums, communicating complex scientific information concisely to executive audiences.
- Monitor the oncology innovation landscape in China, the cross-border licensing and partnering environment, and relevant regulatory and policy developments in the United States and China, and advise leadership on their implications for portfolio strategy.
3. Partnership Development and Global Development Strategy
- Engage peer-to-peer, in Mandarin and English, with chief medical officers, chief scientific officers, founders, and principal investigators of biotechnology companies and academic laboratories in China to build trusted relationships and support partnership discussions.
- Develop global clinical development plans for partnered assets that bridge early-phase data from China to multiregional clinical trials (MRCTs), including dose-optimization strategy, indication sequencing, registrational trial design, and endpoint selection.
- Advise partners on global regulatory strategy, including preparation for Investigational New Drug (IND) applications, pre-IND and end-of-phase meetings with FDA, scientific advice procedures with EMA, and integration of data generated under the oversight of China’s National Medical Products Administration (NMPA) into global submissions.
- Through the PPD consulting practice, provide industry-leading product development plans and top-level design of the clinical trial protocols required by those plans.
- Support proposals, bid defenses, and client governance and advisory boards for partnered programs, including interactions with partner physicians and indication leaders.
- Author and review Investigator’s Brochures, clinical study reports, regulatory briefing documents, and clinical sections of New Drug Applications (NDAs), Biologics License Applications (BLAs), and Marketing Authorization Applications (MAAs).
4. Cross-Functional Collaboration and Internal Expertise
- Work within a multidisciplinary diligence team that includes business development, corporate strategy, regulatory affairs, clinical operations, biostatistics, and commercial colleagues, ensuring that medical and scientific perspectives are fully integrated into recommendations.
- Liaise with investigators and key opinion leaders (KOLs) in China, the United States, and Europe to inform asset assessments and trial feasibility.
- Contribute to the design and reporting of feasibility assessments for global trials of partnered assets.
- Provide indication-specific training and guidance to internal clinical teams, and mentor and supervise clinical scientists.
- Participate in multidisciplinary working groups and initiatives that strengthen Thermo Fisher Scientific’s capabilities in supporting cross-border oncology development.
Minimum Qualifications:
- Doctor of Medicine (MD) or equivalent required.
- Board certification, or equivalent, in medical oncology, hematology and oncology, or a closely related specialty.
- At least five years of experience in the pharmaceutical or biotechnology industry leading oncology clinical development, including leadership of at least one asset from discovery through registration.
- Demonstrated experience evaluating early-phase oncology data and making development or portfolio recommendations.
- Proficiency in spoken and written English and Mandarin Chinese.
- Active medical license preferred but not required.
Preferred Qualifications:
- Direct experience with oncology programs originating in China, including clinical development under NMPA oversight or the transition of China-originated assets into global development.
- Experience conducting scientific due diligence for in-licensing, partnering, or investment decisions in a pharmaceutical business development, venture capital, or corporate strategy setting.
- Experience designing or leading MRCTs, and familiarity with the FDA Oncology Center of Excellence’s Project Optimus dose-optimization initiative and with FDA and EMA expectations for global registration.
- An established professional network among oncology investigators, biotechnology leaders, and academic institutions in China.
- Experience presenting to executive leadership teams, boards, or investment committees.
Knowledge, Skills and Abilities:
- Rigorous, independent scientific judgment, with the ability to reach clear and defensible conclusions from incomplete or heterogeneous data.
- Able to work effectively in a matrix organization.
- Able to demonstrate the following key high-performance behaviors: decisive, customer driven, flexible thinking, smart risk-taking, and continuous improvement.
- Leads, influences, and motivates staff within and across departments.
- Strong in presenting and communicating complex information clearly to scientific and executive audiences.
- Able to work effectively across Chinese and Western business and scientific cultures.
- Able to handle sensitive and confidential information, including nonpublic data from prospective partners, with discretion.
- Possesses a “can do” attitude and is capable of implementing and following through on activities and projects.
- Flexibility to travel domestically and internationally, including periodic travel to China.
What We Offer:
- Full-time position
- Base salary plus a competitive bonus, equity, and benefits package
- Exposure to a broad portfolio of novel oncology assets across modalities and stages of development
- The opportunity to contribute to a strategic Thermo Fisher Scientific initiative supporting the global development of oncology innovation originating in China
Compensation
The estimated annualized pay range for this position in Oregon is $300,000.00–$400,000.00.